Is a complete AZN research report available?

No complete published report is available for AstraZeneca PLC (AZN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

AZN Stock Analysis, Forecast & Valuation

Market cap	267B
Revenue (ttm)	61.4B
Net income (ttm)	10.4B
EPS (ttm)	$6.68
Shares out	1.6B
P/E (trailing)	25.6x
P/E (forward)	15.9x
Dividend	$3.23 (1.87%)
Volume	4,739,178

Beta	0.23

Price target	$214	+23.8%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All AZN indicators

Market & fundamental data

Available fields

288

Groups with data

Currency

USD

Showing 288 of 288 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000901832
Company name	AstraZeneca PLC
Country	United Kingdom
Country code	US
Cusip	G0593M107
Employees	95,100
Employees Change	2,200%
Employees Change Percent	2.37
Enterprise value	$294.5B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - General
Industry PE	27.58
Industry PE Fwd	19.22
IPO Date	1993-05-12
Isin	GB0009895292
Last refreshed	2026-07-29
Market cap	$267B
Market cap category	Mega-Cap
Price	$172
Price currency	USD
Rev Per Employee	645,278.65x
Sector	Healthcare
Sector PE	45.13
Sector PE Fwd	23.9
Sic	2834
Symbol	AZN
Website	https://www.astrazeneca.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.91%
EV Earnings	28.2x
EV Sales Forward	4.58x
EV/EBIT	21.08x
EV/EBITDA	14.49x
EV/FCF	27.61x
EV/Sales	4.8x
FCF yield	4%
Forward P/E	15.9x
P/B ratio	5.3x
P/E ratio	25.56x
P/S ratio	4.35x
PE Ratio10 Y	84.65x
PE Ratio3 Y	30.99x
PE Ratio5 Y	130.79x
PS Forward	4.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.77%
EBITDA Margin	33.12%
FCF margin	17.38%
Gross margin	81.69%
Gross Profit	$50.1B
Gross Profit Growth	7.69%
Gross Profit Growth Q	7.25%
Gross Profit Growth3 Y	9.19%
Gross Profit Growth5 Y	17.24%
Net Income	$10.4B
Net Income Growth	25.93%
Net Income Growth Q	2.33%
Net Income Growth Quarters	11%
Net Income Growth Years	4%
Net Income Growth3 Y	19.23%
Net Income Growth5 Y	22.6%
Pretax Margin	20.51%
Profit Margin	17.02%
Profit Per Employee	$109,842
Profitable Quarters	$18
Profitable Years	24
ROA	8.02
Roa5y	5.95
ROCE	16.58
ROE	21.96
Roe5y	13.03
ROIC	16.05
Roic5y	13.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.68%
Cagr15y	10.99%
Cagr1y	19.47%
Cagr20y	7.69%
Cagr3y	8.46%
Cagr5y	9.4%
Div CAGR10	5.45%
Div CAGR3	47.82%
Div CAGR5	2.9%
EPS Growth	25.84
EPS Growth Q	2.55
EPS Growth Quarters	11
EPS Growth Years	4
EPS Growth3 Y	19.13
EPS Growth5 Y	18.4
FCF Growth	-4.55%
FCF Growth Q	-22.92%
FCF Growth3 Y	5.66%
FCF Growth5 Y	14.81%
OCF Growth	2.32%
OCF Growth Q	-15.39%
OCF Growth10 Y	14.02%
OCF Growth3 Y	10.41%
OCF Growth5 Y	16.27%
Revenue Growth	8.61x
Revenue Growth Q	6.41x
Revenue Growth Quarters	13x
Revenue Growth Years	7x
Revenue Growth3 Y	11.32x
Revenue Growth5 Y	15.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.54
Assets	$115.8B
Cash	$5B
Current Assets	$28B
Current Liabilities	$31.6B
Debt	$32.4B
Debt EBITDA	$1.59
Debt Equity	$0.64
Debt FCF	$3.03
Equity	$50.4B
Interest Coverage	9.92
Liabilities	$65.5B
Long Term Assets	$87.9B
Long Term Liabilities	$33.9B
Net Cash	$-27.4B
Net Cash By Market Cap	$-10.25
Net Debt EBITDA	$1.35
Net Debt Equity	$0.54
Net Debt FCF	$2.57
Tangible Book Value	$-8.6B
Tangible Book Value Per Share	$-5.55
WACC	5.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.89
Inventory Turnover	1.68
Net Working Capital	$-2.2B
Quick ratio	0.66
Working Capital	$-3.6B
Working Capital Turnover	$-14.99

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.03%
Dividend Growth	3.19%
Dividend Growth Years	1%
Dividend per share	$3.23
Dividend Years	3
Dividend Yield	1.87%
Ex Div Date	2026-08-07
Last Dividend	$1.06
Payout Frequency	Semi-Annual
Payout Ratio	48.35%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	229.99%
1Y total return	19.46%
200-day SMA	184
3Y total return	27.6%
50-day SMA	179.9
50-day SMA vs 200-day SMA	50under200
5Y total return	56.72%
All Time High	212.7
All Time High Change	-18.91%
All Time High Date	2026-02-18
All Time Low	30.2
All Time Low Change	471.13%
All Time Low Date	2009-03-05
ATR	4.72
Beta	0.23
Ch YTD	-1.72
High	174.4
High52	212.7
High52 Date	2026-02-18
High52ch	-18.91%
Low	170.7
Low52	141.8
Low52 Date	2025-08-08
Low52ch	21.66%
Ma50ch	-4.11%
Premarket Change Percent	0.44
Premarket Price	$170
Premarket Volume	45,601
Price vs 200-day SMA	-6.25%
RSI	46.46
RSI Monthly	52.89
RSI Weekly	44.13
Sharpe ratio	0.65x
Sortino ratio	1.2
Total Return	1.9%
Tr YTD	-0.69
Tr15y	377.83%
Tr1m	-8.45%
Tr1w	1.85%
Tr3m	-8.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	6
Analyst Price Target Top	$221
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$1.52
Earnings EPS Estimate Growth	39.45
Earnings Revenue Estimate	15,425,840,480x
Earnings Revenue Estimate Growth	6.7x
Operating Income	$14.6B
Operating Income Growth	3.36
Operating Income Growth Q	2.88
Operating Income Growth3 Y	9.1
Operating Income Growth5 Y	30.69
Operating margin	23.86
Price target	$214
Price Target Change	$23.84
Price Target Change Top	$28.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,543,230,726%
Float Percent	99.5%
Net Borrowing	-1,888,000,000
Shares Insiders	0.04%
Shares Institutions	74.21%
Shares Out	1,551,000,000
Shares Qo Q	-0.06%
Shares Yo Y	-0.03%
Short Float	0.16%
Short Ratio	1
Short Shares	0.16

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$10.3B
Adjusted OCF	13,334,000,000
Average Volume	2,911,805.15x
Bv Per Share	32.43
CAPEX	$-3B
Ch10y	180.9
Ch15y	246.1
Ch1m	-8.45
Ch1w	1.85
Ch1y	17.4
Ch20y	190.4
Ch3m	-8.02
Ch3y	22.81
Ch5y	50.84
Ch6m	-8.29
Change	1.67%
Change From Open	1.04
Close	169.6
Days Gap	0.62
Depreciation Amortization	5,265,000,000
Dollar Volume	817,413,421.4
Earnings Date	2026-07-27
Earnings Time	bmo
EBIT	$14B
EBITDA	$20.3B
EPS	$6.68
F Score	7
FCF	$10.7B
FCF EV Yield	3.62x
FCF Per Share	$6.88
Financing CF	-7,680,000,000
Fiscal Year End	December
Founded	1,992
Goodwill	21,181,000,000
Graham Number	70.29876
Graham Upside	-59.25
Income Tax	$2.1B
Investing CF	-8,151,000,000
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-07-27
Last Report Date	2026-06-30
Last Split Type	Never
Last10k Filing Date	2026-02-24
Lynch Fair Value	$153
Lynch Upside	-11.58
Ma150	187.8
Ma150ch	-8.18%
Ma20	175.8
Ma20ch	-1.86%
Net CF	-2,148,000,000
Next Earnings Date	2026-11-05
Open	170.7
Optionable	Yes
P FCF Ratio	25.03
P FCF Ratio SBC	25.92
P OCF Ratio	19.49
P OCF Ratio SBC	20.02
Payment Date	2026-09-08
Position In Range	48.01
Post Close	172.5
Postmarket Change Percent	-0.86
Postmarket Price	$171
Ppne	16,300,000,000
Pre Close	169.6
Price Date	2026-07-28
Price EBITDA	$13.14
Relative Volume	1.63x
Revenue	61,366,000,000x
SBC By Revenue	0.6x
Share Based Comp	366,000,000
Tax By Revenue	3.48x
Tax Rate	16.95%
Tr20y	339.79%
Tr6m	-7.32%
Views	244
Volume	4,739,178
Z Score	3.57

AstraZeneca PLC (AZN)

Coverage state: Market snapshot only — no published research

Generate the first AZN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · AZN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AZN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on AZN

Frequently asked questions